Skip to main content
Last Updated
In the Matter of Boston Scientific Corporation and Guidant Corporation
FTC Matter/File Number
0610046
Enforcement Type
Part 2 Consents

Case Summary

The consent order settles charges that the $27 billion acquisition of Guidant Corporation by Boston Scientific Corporation would harm competition and consumers in several significant medical device markets. Guidant Corporation by Boston Scientific Corporation are the largest market shareholders in several coronary medical device markets in the U.S., together accounting for 90% of the U.S. PTCA balloon catheter market and 85% of the U.S. coronary guidewire market.